FLSM
SNDX icon

Frazier Life Sciences Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Frazier Life Sciences Management’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-600,000
Closed -$8.71M – 55
2023
Q3 		$8.71M Sell
600,000
-3,108,838
-84% -$58.8M 0.58% 32
2023
Q2 		$77.6M Hold
3,708,838
– – 4.64% 8
2023
Q1 		$78.3M Hold
3,708,838
– – 5.67% 6
2022
Q4 		$94.4M Buy
3,708,838
+296,000
+9% +$6.9M 5.87% 6
2022
Q3 		$82M Buy
3,412,838
+217,435
+7% +$4.88M 6.31% 5
2022
Q2 		$61.5M Hold
3,195,403
– – 5.8% 6
2022
Q1 		$55.5M Buy
+3,195,403
New +$53.8M 4.73% 8

Other funds holding SNDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
EP
Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return